29Jul
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer
On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By:
Manatt, Phelps & Phillips, LLP
Related
As we have written here, the day before California’s controversial AB 5 was set to go into effect, ...
Read More >
Employers should realize by now that misclassification of employees as independent contractors can r...
Read More >
On September 24, 2019, the Department of Labor announced its final rule updating the salary threshol...
Read More >
In February 2012, an Invenergy affiliate named California Ridge Wind Energy LLC (“California Ridge”...
Read More >
It is no secret that traditional employers often benefit from non-traditional workplace arrangements...
Read More >
As part of World Law Group's 2020 Fall eConference, the International Corporate Transactions and Res...
Read More >